Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Bannert

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
BMC Public Health|August 16, 2014
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven samplingRuth Zimmermann, Ulrich Marcus, Dirk Schäffer, et al.
Chemmedchem|January 22, 2008
Inhibition of HIV-1 by a peptide ligand of the genomic RNA packaging signal PsiJulia Dietz, Joachim Koch, Ajit Kaur, et al.
BMC Public Health|September 7, 2016
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14)Benjamin Wenz, Stine Nielsen, Martyna Gassowski, et al.
Medical Microbiology and Immunology|February 10, 2020
Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infectionPaul R Wratil, Holger F Rabenau, Josef Eberle, et al.
Retrovirology|June 1, 2013
LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virionsBelete Ayele Desimmie, Rik Schrijvers, Jonas Demeulemeester, et al.
Retrovirology|July 31, 2020
Correction to: LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virionsBelete Ayele Desimmie, Rik Schrijvers, Jonas Demeulemeester, et al.
The Journal of Infectious Diseases|July 26, 2012
Influenza A viruses target type II pneumocytes in the human lungViola K Weinheimer, Anne Becher, Mario Tönnies, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2019
Piloting a surveillance system for HIV drug resistance in the European UnionMarita Jw van de Laar, Arnold Bosman, Anastasia Pharris, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 12, 2023
[Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections]Daniel Schmidt, Christian Kollan, Knud Schewe, et al.
Plos Biology|July 14, 2017
Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in EuropeFrançois Blanquart, Chris Wymant, Marion Cornelissen, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
BMC Public Health|August 16, 2014
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven samplingRuth Zimmermann, Ulrich Marcus, Dirk Schäffer, et al.
Chemmedchem|January 22, 2008
Inhibition of HIV-1 by a peptide ligand of the genomic RNA packaging signal PsiJulia Dietz, Joachim Koch, Ajit Kaur, et al.
BMC Public Health|September 7, 2016
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14)Benjamin Wenz, Stine Nielsen, Martyna Gassowski, et al.
Medical Microbiology and Immunology|February 10, 2020
Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infectionPaul R Wratil, Holger F Rabenau, Josef Eberle, et al.
Retrovirology|June 1, 2013
LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virionsBelete Ayele Desimmie, Rik Schrijvers, Jonas Demeulemeester, et al.
Retrovirology|July 31, 2020
Correction to: LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virionsBelete Ayele Desimmie, Rik Schrijvers, Jonas Demeulemeester, et al.
The Journal of Infectious Diseases|July 26, 2012
Influenza A viruses target type II pneumocytes in the human lungViola K Weinheimer, Anne Becher, Mario Tönnies, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2019
Piloting a surveillance system for HIV drug resistance in the European UnionMarita Jw van de Laar, Arnold Bosman, Anastasia Pharris, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 12, 2023
[Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections]Daniel Schmidt, Christian Kollan, Knud Schewe, et al.
Plos Biology|July 14, 2017
Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in EuropeFrançois Blanquart, Chris Wymant, Marion Cornelissen, et al.
Pageof 12